Meet our speaker - Marcin Szumowski

Marcin Szumowski

Marcin Szumowski

OncoArendi Therapeutics

Marcin Szumowski

OncoArendi Therapeutics

BIO

President and CEO. Marcin has over 15 years of experience in technology transfer, R&D project and life science investment management. He has been involved in preparation and management of more than 40 R&D and investment projects with a combined budget of over 200 million euro. He has founded and/or managed several life science start-ups, including Medicalgorithmics SA, where he was the CEO since its founding in 2005 until 2010. Medicalgorithmics currently is listed on the Warsaw Stock Exchange (GPW, ticker MDG) with market capitalization over 1.2 billion PLN (300M USD) and high percentage of export sales. Marcin has been responsible for establishing a technology transfer platform within a bio-tech-med cluster (BTM Mazovia) formed around a 100 million euro Centre for Preclinical Research and Technology (CePT) investment project. The cluster brings together the three largest Warsaw universities, seven Polish Academy of Science institutes, several Polish biotech and biomed companies, VC and seed funds.

In Impact’18 Agenda

Day I 13.06.2018 Wednesday 17:05 – 17:30
Stage: S2
Track: biotechnology & digital health
Moderated discussion
“Act now! Building a competitive Polish biotechnology ecosystem “